找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Discovery and Development; From Targets and Mol Ramarao Poduri Book 2021 Springer Nature Singapore Pte Ltd. 2021 Drug discovery.Pharma

[復制鏈接]
樓主: Covenant
31#
發(fā)表于 2025-3-27 00:32:49 | 只看該作者
32#
發(fā)表于 2025-3-27 01:43:07 | 只看該作者
https://doi.org/10.1007/978-3-7091-8827-9n research and development of stem cells, selecting the source for stem cells, various feasible applications of stem cells, pharmacological bridging with stem cells, preclinical safety evaluation of stem cells, and finally a section on potential applications of stem cells in future.
33#
發(fā)表于 2025-3-27 05:49:49 | 只看該作者
Negative und komplexe Zahlen, Polynome,horough knowledge of the toxicological potential of nanocarriers. Further, the harmonious integration of academia, researcher, industries and regulatory bodies is warranted to ensure the proper regulation of their use.
34#
發(fā)表于 2025-3-27 10:29:33 | 只看該作者
Genetics and Drug Discovery,iew about the mechanisms involved and aim for new drug candidates. Here in this chapter, we discuss the overview of the basic principles involved in genetics, genetic mutations, and related methods engaged in drug discovery.
35#
發(fā)表于 2025-3-27 15:56:09 | 只看該作者
Discovery and Development of Stem Cells for Therapeutic Applications,n research and development of stem cells, selecting the source for stem cells, various feasible applications of stem cells, pharmacological bridging with stem cells, preclinical safety evaluation of stem cells, and finally a section on potential applications of stem cells in future.
36#
發(fā)表于 2025-3-27 20:16:37 | 只看該作者
37#
發(fā)表于 2025-3-27 21:58:16 | 只看該作者
38#
發(fā)表于 2025-3-28 04:00:29 | 只看該作者
39#
發(fā)表于 2025-3-28 06:32:21 | 只看該作者
Clinical Research in Pharmaceutical Drug Development,g proper endpoints, selecting correct study designs, securing quality data, and statistical analyses..As clinical research encompasses a large?part of?drug development, it is difficult to cover?the subject in detail in one chapter; hence we are providing a high-level?overview.
40#
發(fā)表于 2025-3-28 12:49:55 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 23:16
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
万宁市| 玉门市| 中牟县| 铜川市| 三门峡市| 平罗县| 合肥市| 甘肃省| 如东县| 阳江市| 离岛区| 承德市| 班玛县| 北票市| 汉川市| 藁城市| 聂拉木县| 屏山县| 岢岚县| 进贤县| 东丰县| 秭归县| 延边| 鄂托克前旗| 无极县| 西吉县| 丹棱县| 弥渡县| 囊谦县| 宜阳县| 朝阳县| 佛冈县| 小金县| 商南县| 竹溪县| 浦江县| 祥云县| 黄梅县| 锡林郭勒盟| 通州区| 大兴区|